GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Waypoint Biomedical Holdings Inc (OTCPK:WYPH) » Definitions » EV-to-Revenue

Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) EV-to-Revenue : (As of May. 21, 2024)


View and export this data going back to . Start your Free Trial

What is Waypoint Biomedical Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Waypoint Biomedical Holdings's enterprise value is $0.00 Mil. Waypoint Biomedical Holdings does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Waypoint Biomedical Holdings's EV-to-Revenue at this moment.

The historical rank and industry rank for Waypoint Biomedical Holdings's EV-to-Revenue or its related term are showing as below:

WYPH's EV-to-Revenue is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.935
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Waypoint Biomedical Holdings's stock price is $0.0002. Waypoint Biomedical Holdings does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Waypoint Biomedical Holdings's PS Ratio at this moment.


Waypoint Biomedical Holdings EV-to-Revenue Historical Data

The historical data trend for Waypoint Biomedical Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waypoint Biomedical Holdings EV-to-Revenue Chart

Waypoint Biomedical Holdings Annual Data
Trend
EV-to-Revenue

Waypoint Biomedical Holdings Quarterly Data
EV-to-Revenue

Competitive Comparison of Waypoint Biomedical Holdings's EV-to-Revenue

For the Shell Companies subindustry, Waypoint Biomedical Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waypoint Biomedical Holdings's EV-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Waypoint Biomedical Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Waypoint Biomedical Holdings's EV-to-Revenue falls into.



Waypoint Biomedical Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Waypoint Biomedical Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.004/
=


Waypoint Biomedical Holdings  (OTCPK:WYPH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Waypoint Biomedical Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0002/
=


Waypoint Biomedical Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Waypoint Biomedical Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
370 Amapola Avenue, Suite 200-A, Torrance, CA, USA, 90501
Waypoint Biomedical Holdings Inc is a shell company.

Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) Headlines

No Headlines